KZ
0
Active Trials
1
Total Trials
0
Organizations
0
Events
Kazakhstan
Medical Only (Private)
Reimbursed Care Access
Kazakhstan maintains a restrictive, control-focused approach to classical psychedelics and novel psychoactive compounds: most serotonergic psychedelics (psilocybin, MDMA, DMT, mescaline, 2C‑X, 5‑MeO‑DMT, ibogaine, ayahuasca) are listed in national controlled‑substance schedules with no authorized general medical use outside approved research. Ketamine is registered and used in medical practice (primarily anaesthesia and acute analgesia) and is subject to strengthened controls; esketamine (Spravato) does not appear to be registered for routine clinical psychiatric use in Kazakhstan as of available sources.